Skip to main content
Start Project

GHMAP

Class II pathway in Canada

Health Canada market-access overview for class ii devices. Planning intelligence only — not a regulatory determination, approval, or clinical decision support.

Source trackedNorth America
Timelines, fees, and workflow steps on this page are illustrative market-access planning inputs. They are not legal advice, regulatory approval, or a guarantee of registration, reimbursement, or market entry. Professional review with primary-source verification is required before business use.

Regulatory metrics

Planning ranges for this country and device class. Label every figure as illustrative until sources are verified.

Regulatory pathway metrics for Class II in Canada
MetricValueStatus
AuthorityHealth Canada — Medical Device Licence (MDL)Source tracked
Device classClass IIExample only
Average timeline~150 days / ~5 months (illustrative)To be verified
Local representative requiredYes — Canadian importer / establishment licence holderTo be verified
Government / assessment fee~$5,000 USD (illustrative)Source required

Submission workflow

Step-by-step planning outline. Owners and sequence vary by product evidence and authority questions.

  1. 01

    Confirm Health Canada classification

    Apply Canadian classification rules for Class II.

    Owner: Manufacturer

  2. 02

    Secure quality system evidence

    MDSAP or acceptable QMS evidence as required for the class.

    Owner: Manufacturer

  3. 03

    Appoint Canadian importer / EL holder

    Canadian establishment licence holder supports importation.

    Owner: Manufacturer

  4. 04

    Submit Medical Device Licence application

    File MDL dossier and fees through Health Canada processes.

    Owner: Manufacturer / Importer

  5. 05

    Maintain licence and post-market duties

    Incident reporting, licence amendments, and renewals as applicable.

    Owner: Manufacturer / Importer

Frequently asked questions

Is FDA 510(k) accepted instead of an MDL?
Prior approvals may support the dossier but do not replace Health Canada licensing requirements.
What does Distributor Search cover in Canada?
Evidence-based distributor research for one product in one country ($7,500), request-first after scope lock — research only unless outreach add-on is purchased.

Related market-access pages

Cross-links between pathway pages, country intelligence, and certification primers.

Other Canada classes

Country intelligence

Broader market, reimbursement, and procurement context for Canada.

Open country profile

Related certifications

Convert planning into a scoped GHMAP engagement

Public pathway pages are general context. Product-specific decisions use request-first market entry packages with written scope lock before research begins.

$5,000 · 15 business days after complete intake and scope lock

Full Country Intelligence

Product-specific market-entry decision for one healthcare or MedTech product in one target country. Includes the Decision Report, Evidence & Calculations Workbook, a 60-minute analyst debrief, and one consolidated revision round.

$7,500 · 20 business days after complete intake and scope lock

Distributor Search & Qualification

Evidence-based distributor search for one defined MedTech or IVD product in one selected country: 10–15 screened candidates, 10 detailed assessments, and 3–5 recommended for outreach when evidence supports it.

Prefer a shorter briefing first? Request a Regulatory Pathway Brief ($1,800).

Market entry packages

Ready to scope Canada?

GHMAP confirms written scope before Country Intelligence or Distributor Search research begins. Payment never auto-approves introductions or workspace access.

Professional review remains part of every GHMAP deliverable.